Bhubaneswar: Odisha has positioned itself as one of India’s fastest-growing hubs for the pharmaceutical and medical devices industries after attracting major investment interest at the first-ever Odisha Pharma Summit 2025. The state secured investment proposals worth Rs 7,043 crore through the signing of 45 Memorandums of Understanding (MoUs), reflecting strong confidence from industry players in Odisha’s policy framework and infrastructure.
Of the total proposed investment, Rs 6,263 crore represents confirmed commitments that are projected to generate 38,406 direct employment opportunities. In addition, the summit recorded 24 investment intentions valued at Rs 780 crore, which are expected to create jobs for another 6,240 people. These developments underline Odisha’s growing role in strengthening India’s life sciences and healthcare manufacturing ecosystem.
Odisha Pharma Summit 2025 investments Drive Strong Employment Growth
The majority of the MoUs signed at the summit were concentrated in the pharmaceutical sector, with 32 agreements accounting for investments of Rs 2,681 crore. The medical devices segment also witnessed significant traction, with 12 MoUs amounting to Rs 582 crore. Additionally, a major MoU was signed for the development of an industrial park involving an investment of Rs 3,000 crore, further enhancing the state’s industrial capabilities.
Together, these commitments are expected to create thousands of skilled and semi-skilled jobs, supporting Odisha’s objective of inclusive and sustainable industrial development. The focus on employment generation has been a key factor in attracting investors to the state.
New Industrial Parks Strengthen Healthcare Manufacturing Infrastructure
During the summit, the Odisha government announced the establishment of two dedicated industrial parks aimed at accelerating sector-specific growth. One pharmaceutical industrial park will be developed in the Khurda–Nayagarh region, while a separate medical devices park is planned for Khurda. These parks are expected to provide world-class infrastructure, streamlined approvals, and sector-focused facilities for manufacturers.
The new parks are designed to attract both domestic and global companies, helping Odisha emerge as a preferred destination for pharmaceutical formulation, bulk drugs, and advanced medical device manufacturing.
Odisha Pharma Summit 2025 investments Supported by Progressive Policy Framework
A major highlight of the event was the emphasis on the Odisha Pharmaceutical and Medical Devices Policy 2025, which aims to build an innovation-led and employment-oriented life sciences ecosystem. Chief Minister Mohan Charan Majhi stated that the policy offers some of the most competitive incentives in the country, along with smooth and transparent implementation mechanisms.
The policy is expected to encourage research, innovation, and long-term investment while strengthening Odisha’s position in India’s healthcare value chain. With robust policy support and growing investor interest, the state is set to witness accelerated growth in the pharmaceutical and medical devices sectors.
You May Like
Trending Searches Today |
